Effect of electronic fibrobronchoscope alveolar lavage combined with local administration of budesonide on the efficacy of Mycoplasma pneumoniae pneumonia in children
Main Article Content
Keywords
alveolar lavage, budesonide, electronic fibrobronchoscope, Mycoplasma, pneumoniae, pneumonia
Abstract
This study investigates the effect of electronic fibrobronchoscope alveolar lavage combined with local administration of budesonide on the efficacy of treating Mycoplasma pneumoniae pneumonia (MPP) in children. A retrospective analysis was conducted on the clinical data of 100 children with MPP treated at our hospital from April 2022 to April 2024. The patients were divided into an experimental group (50 cases) and a control group (50 cases) based to the treatment method. Both groups received routine treatment, however, the control group was treated with electronic fibrobronchoscope alveolar lavage alone, while the experimental group received electronic fibrobronchoscope alveolar lavage combined with local administration of budesonide. The efficacy of the two treatments was compared. The experimental group showed a significantly higher overall effective rate than the control group (p<0.05). After treatment, the time for cough relief, lung rales resolution, fever reduction, and hospital stay were significantly shorter in the experimental group compared to the control group (p<0.05). One week after treatment, the levels of tidal volume, vital capacity, and peak expiratory flow in the experimental group were higher than those in the control group (p<0.05). Post-treatment levels of WBC and CRP were lower in the experimental group than in the control group (p<0.05). Additionally, the incidence of complications in the experimental group was lower than in the control group (p<0.05). Electronic fibrobronchoscope alveolar lavage combined with local administration of budesonide improves the efficacy of treatment for children with MPP, enhances clinical indicators, reduces inflammation levels, and has high safety, making it worthy of clinical promotion.
References
2 Seda HD, Halil Ö, Şükriye Y, Gül A, Kübra KH, Ceren KZ, et al. Evaluation of the epidemiological, clinical and radiological features of pneumonia cases caused by Mycoplasma pneumoniae in childhood. Mikrobiyoloji Bult. 2023;57(1):14–29. 10.5578/mb.20239902
3 Bo L, Xu C, Ningsheng Y. Clinical analysis of the epidemiology and changes in inflammatory indexes of Mycoplasma pneumonia in acute and recovery stage pediatric patients. Transl Pediatr. 2022;11(10):1645–1655. 10.21037/tp-22-416
4 Peng L, Wei W, Xianhui Z, Jie P, Lina G. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases. Sci Rep. 2024;14(1):5632–5632. 10.1038/s41598-024-55311-2
5 Ying C, Yan Z, Ni TQ, Bo SH. Efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods. Italian Journal of Pediatrics. 2024;50(1):38. 10.1186/s13052-024-01615-y
6 Le W, Sukun L, Yinghui G, Jianhua L, Peng W, Shuo Y. Comparative study of diagnostic efficacy of sputum and bronchoalveolar lavage fluid specimens in community-acquired pneumonia children treated with fiberoptic bronchoscopy. BMC Infect Dis. 2023;23(1):565. 10.1186/s12879-023-08522-3
7 Ya L, Wei Y, Xin W, Xiaohua G. Effect of bronchofiberscopic lavage with budesonide suspension on refractory Mycoplasma pneumoniae pneumonia. Pak J Med Sci. 2022;38(4Part-II):922–927. 10.12669/pjms.38.4.4835
8 Yanli W, Kai L, Chuangui C, Chengyun Z. Acetylcysteine and budesonide for the treatment of refractory Mycoplasma pneumoniae pneumonia in children: a clinical observation. Ital J Pediatr. 2023;49(1):80–80. 10.1186/s13052-023-01491-y
9 Chen J, Zhu Y, Zheng C, Zhao W, Liu Q. Clinical efficacy of budesonide combined with acetylcysteine in the treatment of Mycoplasma pneumoniae infection. Immunol Inflam Dis. 2023;11(11):e1068–e1068. 10.1002/iid3.1068
10 Xiang Wq, Xu Jl, Aliahmed F, Chen Yh, Li W. Epidemiological Characteristics of Mycoplasma pneumoniae in Hospitalized Children with Pneumonia in Hangzhou, China. Iran J Pediatr. 2020;30(2). 10.5812/ijp.99960
11 Xu M, Li Y, Shi Y, Liu H, Tong X, Ma L, et al. Molecular-epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020-2022. BMC Microbiol. 2024;24(1):23. 10.1186/s12866-024-03180-0
12 Leng M, Yang J, Liu X. Macrolide-resistant mycoplasma pneumoniae infection in children observed during a period of high incidence in Henan, China. Heliyon. 2024;10(13):e33697–e33697. 10.1016/j.heliyon.2024.e33697
13 Akira Y, Machiko A, Hiromasa T, Fumiaki T, Chikatoshi S, Hiromitsu S, et al. Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia. Respir Res. 2021;22(1):115. 10.1186/s12931-021-01726-8
14 Sa RN, Wang AQ, Gao YH, Li XA, Hugejiletu. Efficacy of bronchoalveolar lavage combined with prone positioning in children with Mycoplasma pneumoniae pneumonia and atelectasis: a prospective randomized controlled study. Chin J Contemp Pediatr. 2024;26(1):31–36.
15 Qian W, Wei Z. Clinical effect analysis of budesonide atomization inhalation in the treatment of neonatal pneumonia. MEDS Clin Med. 2023;4(7). 10.23977/medsc.2023.040715
16 Xiang W, Zuozhou X, Jinhong Z, Yi L. Analysis of clinical symptoms improvement in treatment of severe pneumonia caused by multi-drug resistant bacterial infection by bronchoscopy alveolar lavage. J Clin Nurs Res. 2021;5(4):180–184. 10.26689/jcnr.v5i4.2301
17 Hua XX, Feng FH, Ting ST, Yuan YD, Li H, hui JW, et al. Influence of the timing of bronchoscopic alveolar lavage on children with adenovirus pneumonia: a comparative study. BMC Pulm Med. 2021;21(1):363. 10.1186/s12890-021-01708-y
18 Huajun Z, Congling S, Zhongcui Y. Effect of azithromycin sequential therapy combined with budesonide nebulization on chest CT changes in children with Mycoplasma pneumonia. Minerva Gastroenterol. 2023;69(3):447–449. 10.23736/S2724-5985.23.03373-9
19 Yu Y, Chen C. Clinical observation of aerosol inhalation of azithromycin combined with budesonide suspension in the treatment of Mycoplasma pneumoniae pneumonia in children. Panminerva Med. 2021. 10.23736/S0031-0808.20.04260-3
20 Wang C, Feng G, Yang S, Zhang Y. The efficacy of budesonide nebulized inhalation combined with antibiotics in the treatment of pneumonia. Minerva Surg. 2024. 10.23736/S2724-5691.24.10224-9
21 Rokkas T, Niv Y, Malfertheiner P. A network meta--analysis of randomized controlled trials on the treatment of eosinophilic esophagitis in adults and children. J Clin Gastroenterol. 2021;55(5):400–410. 10.1097/MCG.0000000000001356
22 Vizarraga D, Torres-Puig S, Aparicio D, Pich OQ. The Sialoglycan Binding Adhesins of Mycoplasma genitalium and Mycoplasma pneumoniae. Trends Microbiol. 2021;29(6):477–481. 10.1016/j.tim.2021.01.011
23 Linjuan T, Yunping W, Dong W, Wei L, Yongding W, Zhihe Z, et al. Application of fiberoptic bronchoscopy assisted local injection of budesonide in improving the prognosis of severe pneumonia. Minerva Med. 2021;115(1):88–89. 23736/S0026-4806.21.07609-6.
24 Wang C, Ye S, Wang X, Zhao Y, Ma Q, Wang L. Clinical efficacy and safety of mechanical ventilation combined with fiberoptic bronchoalveolar lavage in patients with severe pulmonary infection. Med Sci Monit. 2019;25:5401. 10.12659/MSM.915507
25 Guoqing L, Ran M. Clinical efficacy of budesonide combined with ambroxol in the treatment of neonatal aspiration pneumonia. Basic Clin Pharmacol Toxicol. 2021;128161–161.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.